Symposium
“Intelligent Oncology – The Potential of AI to Control Cancer“
6. September 2024
MISSION
Bringing together experts from various disciplines to explore the latest advances in AI-assisted cancer research. Our goal is to promote collaboration between researchers, physicians, industry leaders, and other visionaries in the field. By sharing knowledge and expertise, we aim to discover new ways to control cancer through the power of AI.
AIM OF THE CONFERENCE
The theme of the conference is Intelligent Oncology, focusing on harnessing the power of AI to control cancer. Our aim is to present cutting-edge research and innovative approaches in cancer diagnosis, prognosis, and treatment. We aim to identify new research directions, foster collaborations between academia and industry, and facilitate the translation of research findings into clinical practice. By connecting experts in the field, we aim to accelerate progress towards more effective and personalized cancer treatment.
AREAS OF FOCUS
AI in cancer diagnosis/treatment
Computational methods for cancer research
Precision medicine with AI
Ethical, regulatory and governance issues of AI for health
Clinical translation of AI health interventions
Innovative AI technologies/platforms
Interdisciplinary collaborations in cancer
SCIENTIFIC BOARD
Prof. Dr. Dr. Melanie Börries
CRIION Scientific Director Systems Medicine & Medical Center, University of Freiburg
Prof. Dr. Mascha Binder
CRIION Scientific Director Clinical Oncology & University Hospital Basel
Prof. Dr. Joschka Boedecker
CRIION Scientific Director AI & Department of Computer Science, University of Freiburg
Assoc. Prof. Victor Greiff
University of Oslo, Norway
Dr. Maria Kalweit
CRIION Head of Applied AI Research & Department of Computer Science, University of Freiburg
Dr. Gabriel Kalweit
CRIION Head of Fundamental AI Research & Department of Computer Science, University of Freiburg
Prof. Dr. Christoph Merten
EPFL, Switzerland
Dr. Jan Moritz Middeke
University Hospital Dresden, Germany
Prof. em. Dr. Dr. h.c. mult. Roland Mertelsmann
CEO Mertelsmann Foundation & Medical Center, University of Freiburg
Prof. Dr. Adriana Tomic
Boston University, USA
Prof. Dr. Evelyn Ullrich
Goethe University, Ullrich Lab – Laboratory for Experimental Immunology & Cell Therapy, Germany
Prof. Dr. Robert Zeiser
CRIION Scientific Director Translational Oncology & Medical Center, University of Freiburg
PROGRAM 2024
9:30 – 9:50
Introduction
Prof. em. Dr. Dr. h.c. mult. Roland Mertelsmann, Prof. Dr. Joschka Boedecker, CRIION Freiburg, Germany
9:50 – 9:55
Welcome remarks from Baden-Württemberg
Nadyne Saint-Cast, MdL, die Grünen
10:00 – 10:00 Welcome remarks from the University Hospital of Freiburg
Chief Medical Director Prof. dr. Dr. h.c. Frederik Wenz
10:00 – 10:05 Welcome remarks from the Technical Faculty of Freiburg University
10:05 – 10:35
Interpretability, efficency, accessibility & trustworthiness: Building the foundations of applicable AI in oncology
Dr. Maria Kalweit, CRIION, Freiburg, Germany
Coffee break
Session 1: Understanding Cancer Through AI and Computational Biology
This session will explore how AI and computational biology can improve our understanding of cancer.
Chair: Prof. Dr. Robert Zeiser, Univerisity of Freiburg, Germany, Prof. Dr. Adriana Tomic, Boston University, USA
11:00 – 11:30
Knowledge-based machine learning to extract disease mechanisms from multi-omics data
Prof. Julio Saez-Rodriguez, Universität Heidelberg, Germany
11:30 – 12:00
Improving cell segmentation in spatial transcriptomics
Dr. Daniel Jones, Fred Hutch Cancer Center, USA
12:00 – 12.30
Exploring mechanisms and functional heterogeneity in cellular immunotherapies targeting cancer via machine learning analysis of live-imaging
Dr. Maria Alieva, Instituto de Investigaciones Biomédicas de Madrid, Spain
12:30 – 12:40
Best Abstract Award
Lunch break & Poster Presentation
Session 2: Building Trust and Regulation in Artificial Intelligence Models for Medicine
This session will examine how to incorporate trust and regulatory to the development and deployment of AI and computational biology-powered cancer therapies.
Chair: Prof. Dr. Joschka Boedecker, Univerisity of Freiburg, Germany, Dr. Jan Moritz Middeke, University Hospital Dresden, Germany
13:40 – 14:10
New regulatory thinking is needed for ‘at-the-patient-bedside’ AI-based personalised drug and cell therapies in precision oncology
Prof. Steven Gilbert, Technische Universität Dresden, Germany
14:10 – 14:40
An instrument like any other? Ethical considerations on the use of AI in medicine
Dr. Markus Herrmann, NCT Heidelberg, Germany
14:40 – 15.10
A regulator’s perspective on AI-based indications for anti-cancer medicines
Dr. Harald Enzmann, BFARM, Germany
15:10 – 15:20
Best Abstract Award
Coffee break
Session 3: Deploying AI and Computational Biology into Clinical Applications
In this session, speakers will discuss the challenges and opportunities of translating AI and computational biology into clinical practice for cancer diagnosis, prognosis, and treatment.
Chair: Prof. Dr. Melanie Börries, University of Freiburg, Germany, Prof. Dr. Christoph Merten, EPFL, Switzerland,
15:50 – 16:20
The practical usage of AI Applications in routine diagnostics
Sven Maschek, MLL Münchner Leukämieabor, Germany
16:20 – 16.50
AI for better cancer care
Dr. Andre Dekker, Maastricht University Medical Center, Netherlands
16:50 – 17:20
Machine learning for personalized cancer care
Prof. Adam Yala, Berkeley, USA
17:20 – 17:30
Best Abstract Award
17:30 – 17:40
Audience Abstracts Award
17:40 – 17:50
Closing remarks
Prof. Dr. Evelyn Ullrich, Goethe University, Ullrich Lab Frankfurt, Germany
Networking Apéro
CALL FOR ABSTRACTS
Are you a PhD candidate or Postdoc working in research fields that could foster the fight against cancer with Al?
Show what you are working on at the event „Intelligent Oncology – The Potential of Al to Control Cancer“ on September 6th, 2024 in Freiburg! A scientific committee will select abstracts for poster or oral presentation. The top abstracts will receive a EUR 500 award. All presenters are welcome to participate free of charge.
Submit your abstract as PDF until August 15th to posters@intelligent-oncology.org
SPEAKERS
Prof. Adam Yala
Berkeley and UCSF, USA
Prof. Julio Saez-Rodriguez
Universität Heidelberg, Germany
Dr. Andre Dekker
Maastricht University Medical
Center, Netherlands
Prof. Steven Gilbert
Technische Universität Dresden, Germany
Dr. Maria Alieva
Instituto de Investigaciones Biomédicas de Madrid, Spain
Sven Maschek
MLL Münchener Leukämielabor, Germany
Dr. Harald Enzmann
BfArM, Germany
Prof. Dr. Markus Herrmann
NCT Heidelberg, Germany
Dr. Daniel Jones
Fred Hutch Cancer Center, USA
Sponsors & Partners 2024